Optimization of Deep Eutectic Solvent Extraction of Phenolic Acids and Tannins from Alchemilla vulgaris L.

por Kovač, Martina Jakovljević, Jokić, Stela, Jerković, Igor, Molnar, Maja
Publicado 2022

Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster...

por Kovac, Martina, Kostanyan, Lusiné, Mesaros, Narcisa, Kuriyakose, Sherine, Varman, Meera
Publicado 2018

Determination of Suitable Macroporous Resins and Desorbents for Carnosol and Carnosic Acid from Deep Eutectic Solvent Sage (Salvia officinalis) Extract with Assessment of Antiradic...

por Jakovljević Kovač, Martina, Pavić, Valentina, Huđ, Anastazija, Cindrić, Ines, Molnar, Maja
Publicado 2021

Terpenes and Cannabinoids in Supercritical CO(2) Extracts of Industrial Hemp Inflorescences: Optimization of Extraction, Antiradical and Antibacterial Activity

por Jokić, Stela, Jerković, Igor, Pavić, Valentina, Aladić, Krunoslav, Molnar, Maja, Kovač, Martina Jakovljević, Vladimir-Knežević, Sanda
Publicado 2022

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, o...

por Godeaux, Olivier, Kovac, Martina, Shu, Daniel, Grupping, Katrijn, Campora, Laura, Douha, Martine, Heineman, Thomas C., Lal, Himal
Publicado 2017

Towards a Greener Approach for Biomass Valorization: Integration of Supercritical Fluid and Deep Eutectic Solvents

por Vladić, Jelena, Jakovljević Kovač, Martina, Pavić, Valentina, Jokić, Stela, Simić, Siniša, Paiva, Alexandre, Jerković, Igor, Duarte, Ana Rita
Publicado 2023

Comparison of Different Green Extraction Techniques Used for the Extraction of Targeted Flavonoids from Edible Feijoa (Acca sellowiana (O.Berg) Burret) Flowers

por Gil, Katarzyna Angelika, Jokić, Stela, Cikoš, Ana-Marija, Banožić, Marija, Jakovljević Kovač, Martina, Fais, Antonella, Tuberoso, Carlo Ignazio Giovanni
Publicado 2023

7. Can Recombinant Zoster Vaccine Administration Decrease the Use of Herpes Zoster-related Pain Medication Across Randomized Controlled Studies?

por Kim, Joon Hyung, Johnson, Robert, Kovac, Martina, Cunningham, Anthony L, Emmadi, Srikanth, Sullivan, Keith, Dagnew, Alemnew F, Curran, Desmond, Schuind, Anne
Publicado 2020

Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trials

por Kim, Joon Hyung, Johnson, Robert, Kovac, Martina, Cunningham, Anthony L., Amakrane, Mohamed, Sullivan, Keith M., Dagnew, Alemnew F., Curran, Desmond, Schuind, Anne
Publicado 2023

Influenza symptoms and their impact on elderly adults: randomised trial of AS03-adjuvanted or non-adjuvanted inactivated trivalent seasonal influenza vaccines

por van Essen, Gerrit A, Beran, Jiri, Devaster, Jeanne-Marie, Durand, Christelle, Duval, Xavier, Esen, Meral, Falsey, Ann R, Feldman, Gregory, Gervais, Pierre, Innis, Bruce L, Kovac, Martina, Launay, Odile, Leroux-Roels, Geert, McElhaney, Janet E, McNeil, Shelly, Oujaa, Mohammed, Richardus, Jan Hendrik, Ruiz-Palacios, Guillermo, Osborne, Richard H, Oostvogels, Lidia
Publicado 2014